Related Experiment Videos
Gram negative bacillary meningitis in infants and children in developing countries
G O Akpede1, O Adeyemi, E O Ogiji
1Department of Paediatrics, University of Muiduguri Hospital, Nigeria.
East African Medical Journal
|September 1, 1996
Summary
Gram-negative bacillary meningitis (GNBM) is more common in developed nations, with different pathogens and conditions. Delayed presentation is a key difference in developing countries, necessitating treatment strategy revisions.
Area of Science:
- Pediatrics
- Infectious Diseases
- Microbiology
Background:
- Gram-negative bacillary meningitis (GNBM) presents differently in developed versus developing countries regarding pathogens and associated conditions.
- While more common in developed nations, GNBM requires specific attention in developing regions due to distinct epidemiological patterns.
Purpose of the Study:
- To analyze the characteristics and outcomes of Gram-negative bacillary meningitis in postneonatal infants and children in a developing country context.
- To compare the presentation and associated factors of GNBM with meningitis caused by other pathogens and with GNBM cases in developed countries.
Main Methods:
- Retrospective analysis of 104 bacterial meningitis cases, identifying 12 (11.5%) caused by Gram-negative bacilli (GNB).
- Detailed evaluation of seven fully assessable GNBM cases, focusing on clinical presentation, illness duration, comorbidities, and treatment outcomes.
- Statistical comparison of GNBM patient presentation with those having meningitis from "usual" pathogens and with reported data from developed countries.
Main Results:
- In this cohort, GNBM was caused by Klebsiella spp., E. coli, and Coliform spp. in patients aged 3-24 months.
- GNBM cases showed a significant tendency for delayed presentation (over 7 days) compared to other bacterial meningitis cases (6/7 vs. 11/36, p=0.011).
- Outcomes included mortality (3/7), sequelae (3/7), and recovery without sequelae (1/7), with no severe malnutrition or specific abnormalities noted.
Conclusions:
- Delayed presentation is a critical distinguishing factor for GNBM in developing countries.
- Current treatment regimens (e.g., gentamicin/ampicillin) may require revision for GNBM in developing regions.
- Further multicenter studies are essential to guide optimal management strategies for GNBM in diverse settings.